Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 in cancer patients: risk, clinical features, and management
Cuiwei Liu, Yanxia Zhao, Derick Okwan‐Duodu, et al.
Cancer Biology and Medicine (2020) Vol. 17, Iss. 3, pp. 519-527
Open Access | Times Cited: 218

Showing 51-75 of 218 citing articles:

Clinical characteristics, risk factors and outcomes of cancer patients withCOVID‐19: A population‐based study
Jiandong Zhou, Ishan Lakhani, Oscar Hou In Chou, et al.
Cancer Medicine (2022) Vol. 12, Iss. 1, pp. 287-296
Open Access | Times Cited: 9
Health influence of SARS-CoV-2 (COVID-19) on cancer: a review
Rachel Parise, Yiran E Li, Rishi Nadar, et al.
Acta Biochimica et Biophysica Sinica (2022) Vol. 54, Iss. 10, pp. 1395-1405
Open Access | Times Cited: 9
The impact of cancer on the severity of disease in patients affected with COVID-19: an umbrella review and meta-meta-analysis of systematic reviews and meta-analyses involving 1,064,476 participants
Mehmet Emin Arayıcı, Yasemin Başbınar, Hülya Ellıdokuz
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 6, pp. 2221-2229
Open Access | Times Cited: 9
Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis
Zhixian Lin, Jiangfeng Chen, Sunya Han
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 9, pp. 1055-1066
Closed Access | Times Cited: 11
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients
Michalis Liontos, Evangelos Terpos, Elena Kunadis, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 25, Iss. 1, pp. 117-118
Open Access | Times Cited: 11
Severely ill and high-risk COVID-19 patients exhibit increased peripheral circulation of CD62L+ and perforin+ T cells
Kelsey E. Lesteberg, Paula Araya, Katherine A. Waugh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Come for Information, Stay for Support: Harnessing the Power of Online Health Communities for Social Connectedness during the COVID-19 Pandemic
Brian M. Green, Casey A. Hribar, Sara Hayes, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 23, pp. 12743-12743
Open Access | Times Cited: 10
Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic
Brenda Bogaert, Victoria Buisson, Zisis Kozlakidis, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103656-103656
Open Access | Times Cited: 7
Impacts of COVID-19 Pandemic on Dietary Consumption among Chinese Residents: Evidence from Provincial-Level Panel Data
Xiaodong Zheng, Yinglin Wang, Yue Zhang, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 13, pp. 7612-7612
Open Access | Times Cited: 7
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: A systematic review with meta-analysis involving 709.908 participants and 31.732 cancer patients
Mehmet Emin Arayıcı, Nazlican Kipcak, Ufuktan Kayacik, et al.
Research Square (Research Square) (2022)
Closed Access | Times Cited: 7
Impaired T-cell Reactivity in Hematological Malignancy Patients: Insights into SARS-CoV-2 Omicron Infection and Clinical Implications
Xiaodan Luo, Ao Chen, Xian Long, et al.
Frontiers in Medical Science Research (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 1
Racial and Ethnic Inequities in Cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2
Jessica Y. Islam, Cassandra A. Hathaway, Emma Hume, et al.
JAMA Network Open (2024) Vol. 7, Iss. 5, pp. e2412050-e2412050
Open Access | Times Cited: 1
The impact of the California state lockdown during the COVID‐19 pandemic on management of patients with pancreatic ductal adenocarcinoma
Parisa Oviedo, Shohei Burns, Wen‐Pin Chen, et al.
Journal of Surgical Oncology (2024) Vol. 130, Iss. 2, pp. 276-283
Open Access | Times Cited: 1
Prospective monitoring of patients undergoing radiotherapy during COVID-19
Denise Ferreira Silva Alves, Daniela Dornelles Rosa, Luciane Borelli Finatto, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 6
Open Access | Times Cited: 1
Impact of the interval between neoadjuvant immunotherapy and surgery on prognosis in esophageal squamous cell carcinoma (ESCC): a real-world study
Guozhen Yang, Yutong Hong, Xiaomin Zhang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 10
Open Access | Times Cited: 1
Chemotherapy delays among cancer patients in Iran during COVID-19 pandemic
Moein Rast, Pedram Fadavi, Marzieh Nojomi, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
COVID-19 as a nosocomial infection
Victoria A. Knyazeva, Н. В. Габбасова, Н. П. Мамчик, et al.
Sanitarnyj vrač (Sanitary Doctor) (2024), Iss. 6, pp. 403-413
Closed Access | Times Cited: 1
Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium
Karlijn de Joode, Jolien Tol, Paul Hamberg, et al.
European Journal of Cancer (2021) Vol. 160, pp. 261-272
Open Access | Times Cited: 8
Hematologic malignancies and COVID‐19 infection: A monocenter retrospective study
Hamed Azhdari Tehrani, Soodeh Ramezaninejad, Masoud Mardani, et al.
Health Science Reports (2022) Vol. 5, Iss. 3
Open Access | Times Cited: 6
Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics
Jin Wang, Shanbo Ma, Long Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones within an Inflamed Microenviroment
Ioannis Liapis, Stavroula Baritaki
Cancers (2022) Vol. 14, Iss. 17, pp. 4330-4330
Open Access | Times Cited: 6
Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy
Yongbiao Huang, Yuan Wang, Duo Xu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
Determination of the Relationship Between Gynecological Cancer Awareness and Fear of Cancer in Women Using Social Media and the Affecting Factors
Rüveyde Aydın, Fatmanur Sena Karakısla, Kamile Kabukçuoğlu
Cancer Nursing (2023) Vol. 47, Iss. 6, pp. 425-435
Closed Access | Times Cited: 3
Prolonged Viral Shedding in Cancer Patients with Asymptomatic or Mild Omicron Infection: A Retrospective Study
Qiao Yang, Ying He, Yi Zhou, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 7735-7741
Open Access | Times Cited: 3
Cancer metastasis may increase COVID-19 mortality: Suitable targets required to impede cancer metastasis
Md Mohiuddin, Kazuo Kasahara
Journal of Infection and Public Health (2021) Vol. 15, Iss. 2, pp. 153-155
Open Access | Times Cited: 7

Scroll to top